• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchEffector Therapeutics
    Picture of Effector Therapeutics logo

    EFTR — Effector Therapeutics News Story

    $0.000.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      $0.00m
    • Enterprise Value
      -$6.46m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • Discussion
    • EFTR Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    Discussion
    EFTR Dividends
    All News

    NASDAQ RESUMED AT 09:47 AM

    Picture of Effector Therapeutics logoEffector Therapeutics
    25/08/2021 14:47
    NASDAQ RESUMED  LWAC.O  AT 09:47 AM
    

    Recent news on Effector Therapeutics

    See all news
    • Brief: Effector Therapeutics Expects To Incur One-Time Charges And Cash Expenditures

      24/06/2024 12:16
    • Brief: Effector Therapeutics Announces It Will Wind Down Operations

      24/06/2024 12:01
    • Brief: Effector Therapeutics To Collaborate With The Dana-Farber Cancer Institute

      20/05/2024 14:23
    • eFFECTOR Therapeutics Inc reports results for the quarter ended in January - Earnings Summary

      09/05/2024 23:23
    • Brief: eFFECTOR Therapeutics Enters Into An At The Market Offering Agreement With H.C. Wainwright

      09/05/2024 21:56

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.